J.Jill Inc is a national lifestyle brand that provides apparel, footwear, and accessories. The company's products are marketed under the J.Jill brand name and sold through its two channels: its e-commerce platform and catalog (Direct) and its retail stores (Retail). J.Jill caters to a distinctive set of women, typically forty-five years and older, offering them various apparel products, footwear, and accessories, comprising shirts, dresses, tops and tees, sweaters, pants and jeans, jewelry, bags, belts, shoes, scarves, etc. The company's operating segments consist of its Retail channels, which derive maximum revenue, and Direct channels. Geographically, the majority of its revenue is derived from the United States.
Last trade$21.55
Day change+$0.01 (+0.05%)
Day range$21.39 – $21.85
Volume55,087
Market cap$320M
OpenXNYS
Fundamentals
Key company ratios and reported financial statements.
Source: Massive.com
Key ratios
Valuation
Market capitalization
$320.15M
Price / earnings
11.79×
Price / book
2.29×
Price / sales
0.54×
EV / sales
0.54×
EV / EBITDA
4.55×
Profitability
Earnings per share
$1.83
Return on assets
5.93%
Return on equity
19.41%
Dividend yield
1.59%
Liquidity and leverage
Debt / equity
0.52×
Current ratio
1.3×
Quick ratio
0.86×
Cash ratio
0.64×
Cash flow
Price / cash flow
4.9×
Price / free cash flow
6.58×
Free cash flow
$48.64M
Ratios use trailing-twelve-month financials and market data as of
Nov 16, 2026.
Financial statements
Income and cash flow amounts are for the period; balance sheets are point-in-time
snapshots. Amounts are shown in USD. Latest 8 quarterly or 5 annual periods are
displayed when available.
Income statement for JILL, quarterly periods
Line item
Q2 FY2027 Aug 1, 2026
Q1 FY2027 May 2, 2026
Q4 FY2026 Jan 31, 2026
Q3 FY2026 Nov 1, 2025
Q2 FY2026 Aug 2, 2025
Q1 FY2026 May 3, 2025
Q4 FY2025 Feb 1, 2025
Q3 FY2025 Nov 2, 2024
Revenue
$154.83M
$144.43M
$138.41M
$150.53M
$153.99M
$153.62M
$142.84M
$151.26M
Cost of revenue
$35.85M
$45.73M
$51.1M
$43.81M
$48.63M
$43.27M
$48.09M
$43.29M
Gross profit
$118.98M
$98.69M
$87.31M
$106.72M
$105.36M
$110.36M
$94.75M
$107.98M
Selling, general and administrative
$94.65M
$89.72M
$86.99M
$91.8M
$88.57M
$91.09M
$89.31M
$88.65M
Research and development
$0
$0
$0
$0
$0
$0
$0
$0
Total operating expenses
$94.7M
$89.93M
$90.58M
$91.8M
$88.57M
$91.3M
$89.67M
$88.75M
Operating income
$24.28M
$8.76M
-$3.27M
$14.92M
$16.78M
$19.06M
$5.08M
$19.23M
Interest expense
-$1.9M
-$1.87M
-$2.21M
-$2.7M
-$2.73M
-$2.79M
-$2.69M
-$2.85M
Income before taxes
$23.49M
$7.24M
-$4.94M
$12.79M
$14.55M
$16.66M
$2.92M
$16.87M
Income taxes
$6.72M
$2.55M
-$1.42M
$3.58M
$4.03M
$4.97M
$671K
$4.52M
Net income
$16.77M
$4.69M
-$3.52M
$9.21M
$10.52M
$11.69M
$2.25M
$12.35M
Net income attributable to common shareholders
$16.77M
$4.69M
-$3.52M
$9.21M
$10.52M
$11.69M
$2.25M
$12.35M
EBITDA
$29.39M
$14.22M
$5.65M
$20.14M
$22.09M
$24.61M
$10.68M
$24.58M
Basic earnings per share
$1.12
$0.32
-$0.23
$0.61
$0.69
$0.76
$0.15
$0.81
Diluted earnings per share
$1.11
$0.31
-$0.23
$0.60
$0.69
$0.76
$0.14
$0.80
Recent news
Company coverage with links to the original publishers.
Genesco reported a quarterly loss of $0.83 per share, beating the consensus estimate of $1.34 loss by 38.06%. Revenue of $529.86 million slightly exceeded expectations by 0.59%, though it declined year-over-year. The stock has gained 35.3% year-to-date, outperforming the S&P 500's 12% gain. The company holds a Zacks Rank #3 (Hold) rating, suggesting near-term performance in line with the market.
Johnson Fistel, PLLC is investigating potential securities fraud claims on behalf of investors in J.Jill, RH, and Viridian Therapeutics. The J.Jill investigation was prompted by the company's March 31, 2026 earnings disclosure revealing poor holiday assortment performance, increased competitive promotions, and customer migration toward discounted pricing, raising questions about compliance with federal securities laws.
J.Jill reported a modest decline in net sales and adjusted net income in Q2 FY2025, with challenges in sales performance and margin compression. The company maintains its dividend and continues to focus on its core customer segment and omnichannel strategy.
J.Jill Inc's President & CEO Claire Spofford sold a significant number of shares, indicating a negative sentiment towards the company's prospects. The stock appears overvalued based on its valuation metrics.
J.Jill CEO Claire Spofford has sold a significant portion of her shares in the company, valued at over $988,000. Despite the sales, Spofford continues to hold a substantial number of shares in J.Jill.
Dividends
Declared distributions and recorded event dates. Forecasts are not
shown.
Updated daily
No declared upcoming dividend found.
Ex-dividend
Amount / share
Pay date
Type
Sep 23, 2026
$0.09
Oct 7, 2026
recurring
Jun 24, 2026
$0.09
Jul 8, 2026
recurring
Apr 14, 2026
$0.09
Apr 28, 2026
recurring
Dec 24, 2025
$0.08
Jan 7, 2026
recurring
Sep 17, 2025
$0.08
Oct 1, 2025
recurring
Stock splits
Historical share-structure events and their execution dates.